Navigation Links
Good Science from RegenceRx Equals Good Value for Michigan's Upper Peninsula Health Plan
Date:3/6/2013

PORTLAND, Ore., March 6, 2013 /PRNewswire/ -- Prescription medications are a key driver of the nation's rising health care costs, and many health care plans are seeking solutions that will provide the best value to their members. With that in mind, Michigan's Upper Peninsula Health Plan (UPHP) has selected RegenceRx to produce rigorous, independent evidence-based assessments of prescription medications, designed to support and maintain UPHP's formulary and medication coverage policies.

UPHP provides benefits to more than 30,000 Medicaid and MIChild members. It ranks among the top 25 Medicaid managed-care plans in the United States, according to the National Committee for Quality Assurance Medicaid Health Insurance Plan Rankings 2012–2013.

"We are honored that the UPHP has chosen RegenceRx as their partner in providing members with safe, effective and affordable medications. We look forward to helping them fulfill our shared commitment to providing cost efficient, quality health care to their members," said Raulo Frear , Pharm. D., general manager of RegenceRx.

"This partnership is a perfect fit for us, as RegenceRx shares the health plan's commitment to provide cost-efficient, high-quality health care to its members," said Sheryl Waudby , M.S., R. Ph., pharmacy director for the Upper Peninsula Health Plan. "We look forward to working with RegenceRx to support our formulary, the foundation of our pharmacy benefits program and our efforts to manage a value-based pharmacy benefit for our members." 

About RegenceRx
The mission of RegenceRx is to ensure that members have affordable coverage for prescription medications. The company is distinguished by its focus on clinical evidence to build its formulary, and its focus on lowest net costs has helped reduce the cost of prescription medications for RegenceRx and their members. RegenceRx currently provides PBM services for more than 1.2 million members of Regence Health Plans. In addition, over 7.7 million members from other Blue Cross and Blue Shield and Medicaid plans trust RegenceRx to provide clinical and contracting support. RegenceRx, Inc. is part of the Cambia Health Solutions family of companies.

About the Upper Peninsula Health Plan
Based in Marquette, Michigan, the Upper Peninsula Health Plan (UPHP) provides benefits to more than 30,000 Medicaid and MIChild members. With a network of more than 900 providers, UPHP also serves as the hub for all commercial managed-care and preferred provider organization (PPO) activity in the Upper Peninsula. UPHP ranks among the top 25 Medicaid managed-care plans in the United States, according to the National Committee for Quality Assurance Medicaid Health Insurance Plan Rankings 2012–2013.


'/>"/>
SOURCE RegenceRx
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HUYA Bioscience Announces Partnership With Shanghai Zhangjiang Biotech Pharmaceutical Base
2. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
3. Particle Sciences and NETZSCH Premier Technologies Enter into Collaboration
4. Dr. Joachim Schorr (PhD) zum Chief Scientific Officer von Caris Life Sciences bestellt
5. Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
6. Oregon Health & Science University Receives Award For Leadership In Advanced Healthcare Technology Solutions
7. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
8. Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
9. Heptares to Present at the 6th Annual European Life Sciences CEO Forum (5-6 March)
10. AUL Files Seventh Brief Supporting First Amendment Freedom of Conscience
11. TCS Named as a Leader in Life Science Drug Safety Services by Leading Industry Research Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... Eli Lilly and Company (NYSE: ... for galcanezumab and lasmiditan, two investigational treatments for migraine, ... (IHC) taking place Sept. 7-10 in Vancouver ... long-term data from an open-label study evaluating the safety ... and 240 mg) for the prevention of migraine. Galcanezumab ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
(Date:9/1/2017)... Sept. 1, 2017  Bayer will present the latest research ... for Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... new preclinical and clinical data on Bayer,s marketed portfolio and ... projects. "We value ... in cancer research at ESMO," said Carsten Brunn , ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... ... Excellence (CoE) with the latest Artificial Intelligence (AI) thinking, announced today the launch ... and easy access to essential information that offers a more comprehensive understanding of ...
(Date:9/20/2017)... ... September 20, 2017 , ... Renal ... for people who have kidney disease. The theme “Describe a positive decision that ... Entrants needed to meet only one qualification— to have been diagnosed with ...
(Date:9/20/2017)... Houston, TX (PRWEB) , ... September 20, 2017 ... ... the date of the much-anticipated fall event , Look Awesome This Autumn ... demonstrations, personalized consultations, special pricing and refreshments. , Mirror Mirror Beauty Boutique ...
(Date:9/20/2017)... ... September 20, 2017 , ... As part of ... recently unveiled a redesigned website. The new site – still located at ... architects, contractors and other industry users that Garland serves. , After an ambitious ...
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short time since going on ... positive feedback from customers trying the product for the first time, and others who ... developed by neurosurgeon Shawn Moore, MD, for everyone from athletes at risk from multiple ...
Breaking Medicine News(10 mins):